Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-11-11-Speech-3-185"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20091111.18.3-185"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I welcome the initiatives and the actions undertaken at European level to combat neurodegenerative diseases and, in particular, Alzheimer’s disease. The Member States have been developing research efforts in this field. It is important that cooperation among Member States is encouraged, to ensure increased coordination in terms of scientific research and technological development, and avoid fragmentation.
Joint programming of research is a valuable tool for reducing fragmentation by involving, at European level, the Member States, the public sector and the private sector. This joint programming tool will be vital for the future of the European Research Area. Developing the European Research Area lies at the heart of the research policy of the Treaty of Lisbon.
However, I am concerned about the implementation of this joint programming tool in terms of bureaucratic complexity and delays in administrative procedures. I would therefore like to ask what the plans are for using a process based on economy of scale, combining efficiency, simplification and fast-tracking of administrative procedures so as to promote excellence and to encourage collaboration at European level, as called for by the importance of this issue."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples